Given that the expression level of CCL8 was negatively associated with the survival time and clinical stages in DLBCL patients, GO enrichment analysis and GSEA were used to investigate the underlying interplay of DESs between high- and low-CCL8 expression groups. The gene discussed is CCL8; the disease is diffuse large B-cell lymphoma.